Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Vaginal epidermal dendritic cells: defense against HIV-1 or a safe haven?

Caucheteux S, Piguet V.

J Clin Invest. 2018 Jul 9. pii: 121744. doi: 10.1172/JCI121744. [Epub ahead of print]

2.

[Pain management in adult medico-surgical wards : practical guidelines].

Luthy C, Chaves-Iselin I, Kupferschmid S, Bollondi-Pauly C, Pautex S, Escher M, Broers B, Rehberg-Klug B, Cedraschi C, Piguet V.

Rev Med Suisse. 2018 Jun 20;14(612):1296-1300. French.

PMID:
29944297
3.

[Opioids prescription in the vulnerable populations : the children and the elderly. Practical guidelines].

Rodieux F, Lloret-Linares C, Piguet V, Desmeules J.

Rev Med Suisse. 2018 Jun 20;14(612):1268-1278. French.

PMID:
29944293
4.

Tinea capitis in children: a systematic review of management.

Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, Tosti A, Friedlander SF.

J Eur Acad Dermatol Venereol. 2018 May 24. doi: 10.1111/jdv.15088. [Epub ahead of print]

PMID:
29797669
5.

Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.

Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V.

J Eur Acad Dermatol Venereol. 2018 May 24. doi: 10.1111/jdv.15081. [Epub ahead of print] Review.

PMID:
29797431
6.

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).

Lebwohl M, Blauvelt A, Paul C, Sofen H, Węgłowska J, Piguet V, Burge D, Rolleri R, Drew J, Peterson L, Augustin M.

J Am Acad Dermatol. 2018 Aug;79(2):266-276.e5. doi: 10.1016/j.jaad.2018.04.013. Epub 2018 Apr 14.

7.

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.

Cooksey R, Brophy S, Kennedy J, Gutierrez FF, Pickles T, Davies R, Piguet V, Choy E.

Semin Arthritis Rheum. 2018 Mar 17. pii: S0049-0172(17)30621-2. doi: 10.1016/j.semarthrit.2018.03.005. [Epub ahead of print]

8.

When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.

Rodieux F, Vutskits L, Posfay-Barbe KM, Habre W, Piguet V, Desmeules JA, Samer CF.

Front Pharmacol. 2018 Mar 5;9:148. doi: 10.3389/fphar.2018.00148. eCollection 2018. Review.

9.

Hot Stuff: Thermal Imaging Aids in Cellulitis Diagnosis.

Drucker AM, Piguet V.

J Invest Dermatol. 2018 Mar;138(3):482-484. doi: 10.1016/j.jid.2017.10.008.

PMID:
29477190
10.

The Ticking CLOCK of HSV-2 Pathology.

Bayliss RJ, Piguet V.

J Invest Dermatol. 2018 Jan;138(1):17-19. doi: 10.1016/j.jid.2017.08.028.

PMID:
29273146
11.

Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study.

Reich K, Gooderham M, Bewley A, Green L, Soung J, Petric R, Marcsisin J, Cirulli J, Chen R, Piguet V.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):397-402. doi: 10.1111/jdv.14738. Epub 2018 Jan 29.

12.

Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.

Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V.

Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.

PMID:
29094346
13.

How to Train to Discharge a Dermatology Outpatient: A Review.

Harun A, Finlay AY, Salek MS, Piguet V.

Dermatology. 2017;233(4):260-267. doi: 10.1159/000479060. Epub 2017 Oct 10.

14.

Evaluation of port site hernias, chronic pain and recurrence rates after laparoscopic ventral hernia repair: a monocentric long-term study.

Liot E, Bréguet R, Piguet V, Ris F, Volonté F, Morel P.

Hernia. 2017 Dec;21(6):917-923. doi: 10.1007/s10029-017-1663-2. Epub 2017 Sep 1.

PMID:
28864912
15.

Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).

Ingram JR, Cawley S, Coulman E, Gregory C, Thomas-Jones E, Pickles T, Cannings-John R, Francis NA, Harding K, Hood K, Piguet V.

Diabet Med. 2018 Feb;35(2):255-261. doi: 10.1111/dme.13431. Epub 2017 Aug 15.

16.

Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.

Ali FM, Kay R, Finlay AY, Piguet V, Kupfer J, Dalgard F, Salek MS.

Qual Life Res. 2017 Nov;26(11):3025-3034. doi: 10.1007/s11136-017-1607-4. Epub 2017 Jun 10.

17.

The pathogenesis of dermatomyositis.

Thompson C, Piguet V, Choy E.

Br J Dermatol. 2017 May 24. doi: 10.1111/bjd.15607. [Epub ahead of print] Review.

PMID:
28542733
18.

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.

FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.

19.

Heat-Induced Editing of HPV Genes to Clear Mucocutaneous Warts?

Piguet V.

J Invest Dermatol. 2017 Apr;137(4):796-797. doi: 10.1016/j.jid.2017.01.015.

20.

Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool.

Atwan A, Piguet V, Finlay AY, Francis NA, Ingram JR.

Br J Dermatol. 2017 Oct;177(4):e136-e137. doi: 10.1111/bjd.15446. Epub 2017 Sep 19. No abstract available.

PMID:
28295196
21.

Understanding clinician influences and patient perspectives on outpatient discharge decisions: a qualitative study.

Harun NA, Finlay AY, Piguet V, Salek S.

BMJ Open. 2017 Mar 6;7(3):e010807. doi: 10.1136/bmjopen-2015-010807.

22.

Bedside or not bedside: Evaluation of patient satisfaction in intensive medical rehabilitation wards.

Luthy C, Francis Gerstel P, Pugliesi A, Piguet V, Allaz AF, Cedraschi C.

PLoS One. 2017 Feb 7;12(2):e0170474. doi: 10.1371/journal.pone.0170474. eCollection 2017.

23.

Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index: evidence of equivalence.

Ali FM, Johns N, Finlay AY, Salek MS, Piguet V.

Br J Dermatol. 2017 Nov;177(5):1306-1315. doi: 10.1111/bjd.15314. Epub 2017 Jun 12.

PMID:
28112800
24.

Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

Atwan A, Ingram JR, Abbott R, Kelson MJ, Pickles T, Bauer A, Piguet V.

Br J Dermatol. 2016 Nov;175(5):873-881. doi: 10.1111/bjd.14676. Epub 2016 Aug 29. Review.

25.

New Cutaneous Vaccine Adjuvant that STINGs a Little Less.

Caucheteux SM, Piguet V.

J Invest Dermatol. 2016 Nov;136(11):2127-2128. doi: 10.1016/j.jid.2016.07.020. Review.

26.

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE).

Reich K, Gooderham M, Green L, Bewley A, Zhang Z, Khanskaya I, Day RM, Goncalves J, Shah K, Piguet V, Soung J.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):507-517. doi: 10.1111/jdv.14015. Epub 2016 Dec 19.

27.

Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision making.

Owen ED, Choy EH, Piguet V.

Br J Dermatol. 2016 Oct;175(4):665-6. doi: 10.1111/bjd.14917. No abstract available.

PMID:
27650736
28.

Image Gallery: Pseudoepitheliomatous hyperplasia, a rare tattoo reaction.

Kiss F, May K, Piguet V.

Br J Dermatol. 2016 Sep;175(3):e112. doi: 10.1111/bjd.14853. No abstract available.

PMID:
27632970
29.

[It is not only about cost ... when it comes to generic medication].

Piguet V, D'Incau S, Besson M, Desmeules J, Cedraschi C.

Rev Med Suisse. 2016 Jun 22;12(524):1230-3. French.

PMID:
27506067
30.

TGFβ Induces a SAMHD1-Independent Post-Entry Restriction to HIV-1 Infection of Human Epithelial Langerhans Cells.

Czubala MA, Finsterbusch K, Ivory MO, Mitchell JP, Ahmed Z, Shimauchi T, Karoo ROS, Coulman SA, Gateley C, Birchall JC, Blanchet FP, Piguet V.

J Invest Dermatol. 2016 Oct;136(10):1981-1989. doi: 10.1016/j.jid.2016.05.123. Epub 2016 Jun 29.

31.

HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.

Coulon PG, Richetta C, Rouers A, Blanchet FP, Urrutia A, Guerbois M, Piguet V, Theodorou I, Bet A, Schwartz O, Tangy F, Graff-Dubois S, Cardinaud S, Moris A.

J Immunol. 2016 Jul 15;197(2):517-32. doi: 10.4049/jimmunol.1600286. Epub 2016 Jun 10.

32.

A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.

Ali FM, Cueva AC, Vyas J, Atwan AA, Salek MS, Finlay AY, Piguet V.

Br J Dermatol. 2017 Mar;176(3):577-593. doi: 10.1111/bjd.14788. Epub 2016 Oct 12. Review.

PMID:
27273146
33.

Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.

Callander J, Robson Y, Ingram J, Piguet V.

Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14726. [Epub ahead of print] Review.

PMID:
27167896
34.

The development and clinical evaluation of a 'traffic-light' design dermatology outpatient discharge information checklist.

Harun NA, Finlay AY, Salek M, Piguet V.

Br J Dermatol. 2016 Sep;175(3):572-82. doi: 10.1111/bjd.14650. Epub 2016 Aug 23.

PMID:
27060980
35.

Polypropylene Sulfide Nanoparticle p24 Vaccine Promotes Dendritic Cell-Mediated Specific Immune Responses against HIV-1.

Caucheteux SM, Mitchell JP, Ivory MO, Hirosue S, Hakobyan S, Dolton G, Ladell K, Miners K, Price DA, Kan-Mitchell J, Sewell AK, Nestle F, Moris A, Karoo RO, Birchall JC, Swartz MA, Hubbel JA, Blanchet FP, Piguet V.

J Invest Dermatol. 2016 Jun;136(6):1172-81. doi: 10.1016/j.jid.2016.01.033. Epub 2016 Feb 16.

36.

Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.

Ingram JR, Hadjieconomou S, Piguet V.

Br J Dermatol. 2016 Aug;175(2):263-72. doi: 10.1111/bjd.14475. Epub 2016 May 2. Review.

PMID:
26873867
37.

Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.

Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V.

Br J Dermatol. 2016 May;174(5):970-8. doi: 10.1111/bjd.14418. Epub 2016 Mar 30. Review.

38.

Amyopathic dermatomyositis: evidence of systemic associations.

Callander J, Piguet V.

Br J Dermatol. 2016 Jan;174(1):21-2. doi: 10.1111/bjd.14340. No abstract available.

PMID:
26790653
39.

Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis.

Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA.

Br J Dermatol. 2016 Apr;174(4):853-61. doi: 10.1111/bjd.14361. Epub 2016 Mar 6. Review.

PMID:
26686685
40.

Molluscum contagiosum and associations with atopic eczema in children: a retrospective longitudinal study in primary care.

Olsen JR, Piguet V, Gallacher J, Francis NA.

Br J Gen Pract. 2016 Jan;66(642):e53-8. doi: 10.3399/bjgp15X688093. Epub 2015 Dec 6.

41.

Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection.

Finsterbusch K, Piguet V.

J Invest Dermatol. 2015 Nov;135(11):2565-2567. doi: 10.1038/jid.2015.293.

42.

Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential.

Chauhan S, Ahmed Z, Bradfute SB, Arko-Mensah J, Mandell MA, Won Choi S, Kimura T, Blanchet F, Waller A, Mudd MH, Jiang S, Sklar L, Timmins GS, Maphis N, Bhaskar K, Piguet V, Deretic V.

Nat Commun. 2015 Oct 27;6:8620. doi: 10.1038/ncomms9620.

43.

Interventions for hidradenitis suppurativa.

Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V.

Cochrane Database Syst Rev. 2015 Oct 7;(10):CD010081. doi: 10.1002/14651858.CD010081.pub2. Review.

PMID:
26443004
44.

Is pholcodine a dangerous cough suppressant?

Ing Lorenzini K, Desmeules J, Piguet V.

Eur J Anaesthesiol. 2015 Nov;32(11):749-50. doi: 10.1097/EJA.0000000000000306. No abstract available.

PMID:
26426574
45.

[Chronic noncancer pain and patient education: a place for e-learning?].

Braillard O, Cedraschi C, Jesaimani A, Piguet V.

Rev Med Suisse. 2015 Jun 24;11(480):1400, 1402-5. French.

PMID:
26267947
46.

[Clinical pharmacology of medical cannabinoids in chronic pain].

Ing Lorenzini K, Broers B, Lalive PH, Dayer P, Desmeules J, Piguet V.

Rev Med Suisse. 2015 Jun 24;11(480):1390, 1392-4. Review. French.

PMID:
26267945
47.

[The use of transdermal opioids in patients in oncological remission suffering from chronic pain].

Oberlé L, Luthy C, Pugliesi A, Pautex S, Piguet V.

Rev Med Suisse. 2015 Jun 24;11(480):1385-9. Review. French.

PMID:
26267944
48.

[Analgesia in patients with hepatic impairment].

Innaurato G, Piguet V, Simonet ML.

Rev Med Suisse. 2015 Jun 24;11(480):1380, 1382-4. Review. French.

PMID:
26267943
49.

[Prescription of antidepressants in the treatment of pain: role of pharmacogenetics].

Rodieux F, Piguet V, Berney P, Desmeules J, Besson M.

Rev Med Suisse. 2015 Jun 24;11(480):1374-9. Review. French.

PMID:
26267942
50.

[Adapting analgesics prescription to the individual: precision medicine].

Allaz AF, Piguet V.

Rev Med Suisse. 2015 Jun 24;11(480):1371-2. French. No abstract available.

PMID:
26267941

Supplemental Content

Loading ...
Support Center